May 2022

B-Secur launches FDA-cleared HeartKey 2.0

Well done to portfolio company, B-Secur, on launching its FDA approved Heartkey® 2.0 product, which should help to power the next generation of medical and consumer devices and platforms. Article from: https://b-secur.com/press/ekg-cloud-tech-improves-accuracy-in-heart-health-monitoring/ The new cloud-based software significantly reduces EKG signal noise, elevating EKG interpretation to new heights of efficiency and accuracy for clinicians and facilitating the […]

B-Secur launches FDA-cleared HeartKey 2.0 Read More »

ABOUT US

Clarendon Fund Managers Limited is a venture capital fund manager based in Belfast, authorised and regulated by the Financial Conduct Authority.

Clarendon Fund Managers Limited is authorised and regulated by the Financial Conduct Authority
The content of the information and materials on the Website and any other information and materials provided by or though CFM in connection with Co-Fund NI and associated investment opportunities and Investee Companies, including any financial promotion as defined in Financial Services and Markets as Act 2000(“FSMA”) constituted thereby, has not been approved by an authorised person within the meaning of FSMA. Reliance on the information provided in relation to any specific Investee Company or otherwise, including any financial promotion constituted thereby, for the purpose of engaging in any investment activity may expose an individual to a significant risk of losing all of the property or other assets invested.

May 2022

B-Secur launches FDA-cleared HeartKey 2.0

ABOUT US

ADDITIONAL LINKS